Global Glass Syringe Market Segmentation, By Syringe Type (Disposable and Reusable), Material Type (Borosilicate Neutral Glass, Surface Treated Borosilicate Glass, and Soda Lime Glass), Capacity (Up To 1 Ml, 1 Ml To 5 Ml, 5 Ml To 20 Ml, and Above 20 Ml), End Use (Hospitals, Research Laboratories, Drug Manufacturing, and Clinical Research) – Industry Trends and Forecast to 2031.
Glass Syringe Market Analysis
The glass syringe market is experiencing steady growth, driven by increasing demand for precise and reliable drug delivery systems in healthcare. Glass syringes are favored in medical and pharmaceutical applications due to their chemical resistance, compatibility with sensitive medications, and ability to maintain drug integrity. The rise in chronic diseases such as diabetes and the growing need for vaccination programs are key factors boosting the demand for glass syringes, particularly in hospitals and clinical settings. Additionally, the trend toward reducing plastic waste is pushing healthcare providers to adopt more sustainable alternatives such as reusable glass syringes. Advancements in manufacturing techniques, such as reinforced glass, are helping mitigate these concerns, further supporting the market's expansion.
Glass Syringe Market Size
Global glass syringe market size was valued at USD 9.15 billion in 2023 and is projected to reach USD 22.82 billion by 2031, with a CAGR of 12.1% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Glass Syringe Market Trends
“Growing Aesthetic and Cosmetic Medical Market”
The growing aesthetic and cosmetic medical market is creating significant opportunities for the adoption of glass syringes, particularly in procedures such as dermal fillers and Botox injections. These treatments require exceptional precision, as even slight deviations in dosage can impact the results or lead to complications. Glass syringes, known for their high accuracy and reliability, are becoming the preferred choice among cosmetic practitioners who demand exact dosing to achieve optimal outcomes. Additionally, the chemical stability of glass syringes ensures that sensitive compounds used in cosmetic treatments maintain their efficacy. With the increasing popularity of non-invasive cosmetic procedures globally, especially in regions such as North America and Europe, the demand for advanced and precise tools like glass syringes is on the rise. This trend is further supported by growing consumer interest in aesthetic enhancements, driving more clinics to adopt high-quality, reusable glass syringes as the standard for cosmetic treatments.
Report Scope and Market Segmentation
|
Attributes
|
Glass Syringe Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Key Market Players
|
BD (U.S.), Gerresheimer AG (Germany), NIPRO (Japan), SCHOTT (Germany), Ompi srl (Italy), Baxter (U.S.), Laboratorios Farmaceuticos ROVI SA (Spain), Terumo Corporation (Japan), RISCREEN GmbH (Germany), Frederick Furness Publishing (U.K.), ARTE Corporation (U.S.), and Shandong Zibo Minkang Pharmaceutical Packing Co., Ltd (China)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
|
Glass Syringe Market Definition
A glass syringe is a medical device made from high-quality, durable glass, designed for administering or withdrawing fluids such as medications, vaccines, or blood. Unlike disposable plastic syringes, glass syringes are typically reusable and can be sterilized for repeated use. They are known for their high chemical resistance, making them suitable for sensitive drugs or compounds that might react with plastic. Glass syringes are often used in medical settings requiring precise dosing, such as in insulin injections, vaccinations, or in laboratory settings where accuracy and material compatibility are crucial. Their transparency also allows easy monitoring of the fluid level and any potential contaminants.
Glass Syringe Market Dynamics
Drivers
- Increasing Demand for Accurate Drug Delivery
Many patients, particularly those with conditions like diabetes, require precise dosages to avoid complications. Glass syringes, known for their superior accuracy and compatibility with sensitive medications, are increasingly favored in healthcare settings. This demand is further reinforced by the use of advanced medications, including biologics, which require precise administration to ensure effectiveness. The high accuracy of glass syringes makes them essential in ensuring that patients receive the correct dosages, ultimately improving treatment outcomes and reducing medication errors. The glass syringe market is primarily driven by the growing need for precise and accurate drug delivery systems, especially in critical care and chronic disease management.
- Rising Chronic Disease Incidence
The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is contributing to the rising demand for glass syringes. These diseases often require long-term treatments and frequent medication administration, making reliability and durability critical. Glass syringes, being reusable and chemically stable, are ideal for delivering medications like insulin, chemotherapy drugs, and hormone therapies. As the number of individuals living with chronic conditions continues to rise globally, the need for glass syringes in administering medications, particularly in long-term care settings, is expected to drive market growth. This demand is especially strong in regions with high incidences of diabetes and cancer, further bolstering the glass syringe market.
Opportunities
- Increasing Use in Biologics and Specialty Drugs
The rising demand for biologics and specialty pharmaceuticals is creating substantial growth opportunities for the glass syringe market. Biologics are highly sensitive to their environment and require materials that do not react with their components. Glass syringes, with their chemical inertness, provide the ideal solution for delivering these medications without compromising their integrity. This makes them the preferred choice for administering high-value biologics, such as monoclonal antibodies and gene therapies. As the pharmaceutical industry continues to develop more complex biologics and personalized medicine, the demand for glass syringes in these applications is expected to grow, creating opportunities for market expansion.
- Collaboration with Pharmaceutical Companies
Collaborations between glass syringe manufacturers and pharmaceutical companies are emerging as a key opportunity for market growth. These partnerships allow manufacturers to develop specialized drug delivery systems tailored to the unique requirements of new and emerging treatments. Such collaborations also help manufacturers align with regulatory standards and streamline the approval process for new syringe designs. For instance, in September 2022, BD, a leading global medical technology company, introduced its next-generation glass prefillable syringe (PFS). The new BD Effivax Glass Prefillable Syringe was developed in collaboration with top pharmaceutical companies to address the complex and evolving requirements of vaccine production. As biopharmaceutical companies expand their vaccine pipelines at a rapid pace, the global demand for prefillable syringes is increasing. These syringes are recognized for their ability to enable faster administration, support dose sparing, and minimize vaccine waste. These partnerships are expected to drive further innovation and expansion in the glass syringe market.
Restraints/Challenges
- High Production Costs
One of the key restraints in the glass syringe market is the high cost of manufacturing compared to plastic alternatives. Glass syringes require specialized materials and production processes, which make them significantly more expensive to produce. This high cost limits their widespread adoption, particularly in cost-sensitive markets where healthcare providers often opt for cheaper plastic syringes. Additionally, the cost of raw materials and labor in glass manufacturing further contributes to the higher price point, their higher production costs remain a barrier to market penetration, especially in developing countries and low-budget healthcare systems.
- Risk of Breakage
Despite their many advantages, glass syringes are prone to breakage, which poses a significant safety risk for both healthcare professionals and patients. This fragility can lead to accidents, particularly in high-pressure medical environments where speed and efficiency are crucial. The risk of broken glass can result in injuries and contamination, making some healthcare providers hesitant to adopt glass syringes, especially in clinical settings that handle high volumes of patients. Although advancements in reinforced glass technology are helping to reduce this issue, the inherent fragility of glass remains a concern. As a result, this limitation hampers the adoption of glass syringes in certain medical environments, where plastic syringes are seen as a safer alternative.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Syringe Market Scope
The market is segmented on the basis of syringe type, material type, capacity, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Syringe Type
- Disposable
- Reusable
Material Type
- Borosilicate Neutral Glass
- Surface Treated Borosilicate Glass
- Soda Lime Glass
Capacity
- Up To 1 Ml
- 1 Ml To 5 Ml
- 5 Ml To 20 Ml
- Above 20 Ml
End Use
- Hospitals
- Research Laboratories
- Drug Manufacturing
- Clinical Research
Syringe Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country syringe type, material type, capacity, and end use as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
Europe is expected to dominate the market due to the significant rise in chronic diseases such as diabetes, cardiovascular conditions, and cancer. These health issues require precise and reliable drug delivery systems, and glass syringes are well-suited for this purpose due to their accuracy and chemical compatibility with sensitive medications. Additionally, the growth of biologics and biosimilars within the region further supports this dominance.
Asia-Pacific is expected to be the fastest growing due to the region's swift urbanization and advancements in healthcare technology. As urban areas expand and the standard of living improves, there is an increased demand for modern medical devices, including glass syringes, which are seen as more reliable for precise drug delivery. Additionally, the rise in healthcare investments and the proliferation of technological innovations in medical devices are further propelling market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Glass Syringe Market Share
The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Glass Syringe Market Leaders Operating in the Market Are:
- BD (U.S.)
- Gerresheimer AG (Germany)
- NIPRO (Japan)
- SCHOTT (Germany)
- Ompi srl (Italy)
- Baxter (U.S.)
- Laboratorios Farmaceuticos ROVI SA (Spain)
- Terumo Corporation (Japan)
- RISCREEN GmbH (Germany)
- Frederick Furness Publishing (U.K.)
- ARTE Corporation (U.S.)
- Shandong Zibo Minkang Pharmaceutical Packing Co., Ltd (China)
Latest Developments in Glass Syringe Market
- In March 2024, SCHOTT Pharma announced plans to expand its operations in the U.S. with a new prefillable syringe manufacturing facility in Wilson, North Carolina. This expansion, involving a USD 371 billioninvestment, will create over 400 jobs in the region. The new facility will be SCHOTT’s first U.S. manufacturing site dedicated to meeting the domestic demand for glass and polymer prefillable syringes used for delivering mRNA, GLP-1, and other therapies
- In August 2023, Nipro unveiled the D2F Pre-fillable Glass Syringe System – Silicone Oil-Free, a novel drug delivery solution tailored for medications that are highly sensitive to silicone oil. This system is specifically designed to meet the needs of drug products requiring a silicone oil-free environment. The D2F Pre-fillable Glass Syringe System – Silicone Oil-Free is manufactured to ENHANCE quality standards, addressing the stringent demands of the pharmaceutical industry and ensuring it meets the precise requirements for handling sensitive drug products and services
SKU-